IL222080B - 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives - Google Patents

6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives

Info

Publication number
IL222080B
IL222080B IL222080A IL22208012A IL222080B IL 222080 B IL222080 B IL 222080B IL 222080 A IL222080 A IL 222080A IL 22208012 A IL22208012 A IL 22208012A IL 222080 B IL222080 B IL 222080B
Authority
IL
Israel
Prior art keywords
thieno
quinolin
derivatives
alkyl
Prior art date
Application number
IL222080A
Other languages
English (en)
Hebrew (he)
Inventor
Nakamura Yusuke
Matsuo Yo
Hisada Shoji
Ahmed Feryan
Huntley Raymond
Sajjadi-Hashemi Zohreh
M Jenkins David
B Kargbo Robert
Cui Wenge
Jolicia F Gauuan Polivina
r walker Joel
Decornez Helene
Gurram Mahender
Original Assignee
Oncotherapy Science Inc
Nakamura Yusuke
Matsuo Yo
Hisada Shoji
Ahmed Feryan
Huntley Raymond
Zohreh Sajjadi Hashemi
M Jenkins David
B Kargbo Robert
Cui Wenge
Jolicia F Gauuan Polivina
r walker Joel
Decornez Helene
Gurram Mahender
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc, Nakamura Yusuke, Matsuo Yo, Hisada Shoji, Ahmed Feryan, Huntley Raymond, Zohreh Sajjadi Hashemi, M Jenkins David, B Kargbo Robert, Cui Wenge, Jolicia F Gauuan Polivina, r walker Joel, Decornez Helene, Gurram Mahender filed Critical Oncotherapy Science Inc
Publication of IL222080B publication Critical patent/IL222080B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL222080A 2010-03-29 2012-09-23 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives IL222080B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31860610P 2010-03-29 2010-03-29
PCT/US2011/030278 WO2011123419A1 (en) 2010-03-29 2011-03-29 Trycyclic compounds and pbk inhibitors containing the same

Publications (1)

Publication Number Publication Date
IL222080B true IL222080B (en) 2018-05-31

Family

ID=44712585

Family Applications (1)

Application Number Title Priority Date Filing Date
IL222080A IL222080B (en) 2010-03-29 2012-09-23 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives

Country Status (15)

Country Link
US (2) US8962648B2 (OSRAM)
EP (1) EP2552206B1 (OSRAM)
JP (1) JP5849302B2 (OSRAM)
KR (1) KR101757502B1 (OSRAM)
CN (1) CN102917590B (OSRAM)
AU (1) AU2011235319B2 (OSRAM)
BR (1) BR112012023836B1 (OSRAM)
CA (1) CA2792941C (OSRAM)
DK (1) DK2552206T3 (OSRAM)
ES (1) ES2547571T3 (OSRAM)
IL (1) IL222080B (OSRAM)
MX (1) MX2012011412A (OSRAM)
SG (1) SG184376A1 (OSRAM)
TW (1) TWI503323B (OSRAM)
WO (1) WO2011123419A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3466949T3 (pl) * 2013-12-24 2021-05-31 Bristol-Myers Squibb Company Związek tricykliczny jako środki przeciwrakowe
TWI557011B (zh) 2015-05-25 2016-11-11 可影像處理的自行車錶裝置
US10464896B2 (en) 2015-06-11 2019-11-05 Basilea Pharmaceutica International AG Efflux-pump inhibitors and therapeutic uses thereof
GB201617758D0 (en) 2016-10-20 2016-12-07 Almac Discovery Limited Pharmaceutical compounds
CN108341774B (zh) * 2017-01-25 2022-07-19 首药控股(北京)股份有限公司 取代的喹啉酮类抑制剂
CN110730776A (zh) 2017-04-10 2020-01-24 拜耳股份公司 取代的n-芳基乙基-2-芳基喹啉-4-甲酰胺及其用途
WO2019094404A1 (en) * 2017-11-07 2019-05-16 Temple University-Of The Commonwealth System Of Higher Education Compositions and methods for improved t cells
CN111099941B (zh) * 2018-10-26 2022-10-18 中国科学院上海有机化学研究所 一种烷基腈类化合物的制备方法
CN117120447A (zh) * 2021-03-18 2023-11-24 薛定谔公司 环状化合物和其使用方法
TW202300150A (zh) * 2021-03-18 2023-01-01 美商薛定諤公司 環狀化合物及其使用方法
CN117362304A (zh) * 2022-07-07 2024-01-09 深圳微芯生物科技股份有限公司 一种甲酰胺取代的杂三环类衍生物、其制备方法及其应用
WO2024097228A1 (en) * 2022-10-31 2024-05-10 Meliora Therapeutics, Inc. Compounds targeting cdk11 and methods of using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377096A (en) * 1976-12-17 1978-07-08 Teijin Ltd Preparation of thieno 2,3-c quinolin-4(5h)-one-7-acetic acids
FR2636063B1 (fr) * 1988-09-05 1993-04-30 Centre Nat Rech Scient Composes phenylpyrroliques utiles en tant que medicaments, leur preparation et leur application
DE19806348A1 (de) * 1998-02-12 1999-08-19 Schering Ag 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln
US6506769B2 (en) 1999-10-06 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
US6638929B2 (en) 1999-12-29 2003-10-28 Wyeth Tricyclic protein kinase inhibitors
CN100432055C (zh) * 1999-12-29 2008-11-12 惠氏公司 三环蛋白激酶抑制剂
DE10242106A1 (de) 2002-09-11 2004-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Phosphorgruppenhaltige Carbonsäurederivate mit organisch polymerisierbaren Gruppen
EA200500342A1 (ru) 2002-09-17 2005-08-25 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си Гетероциклические замещённые пиперазины для лечения шизофрении
AU2003301439A1 (en) * 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
GB0501999D0 (en) * 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
ES2528316T3 (es) * 2006-09-01 2015-02-06 Senhwa Biosciences, Inc. Moduladores de la serina-treonina proteína quinasa y de PARP
CN101754974B (zh) 2007-07-19 2016-02-03 Msd意大利有限公司 作为抗病毒剂的大环化合物
MX2010009445A (es) * 2008-02-29 2011-05-25 Cylene Pharmaceuticals Inc Moduladores de proteina kinasa.

Also Published As

Publication number Publication date
KR101757502B1 (ko) 2017-07-12
EP2552206B1 (en) 2015-07-22
US20150183799A1 (en) 2015-07-02
JP5849302B2 (ja) 2016-01-27
JP2013523749A (ja) 2013-06-17
DK2552206T3 (en) 2015-09-28
HK1179114A1 (en) 2013-09-27
AU2011235319B2 (en) 2016-07-14
BR112012023836A2 (pt) 2015-09-22
TWI503323B (zh) 2015-10-11
AU2011235319A1 (en) 2012-10-11
CN102917590B (zh) 2016-02-17
WO2011123419A1 (en) 2011-10-06
BR112012023836B1 (pt) 2022-02-01
ES2547571T3 (es) 2015-10-07
SG184376A1 (en) 2012-11-29
CN102917590A (zh) 2013-02-06
MX2012011412A (es) 2013-02-07
KR20130020666A (ko) 2013-02-27
CA2792941C (en) 2017-09-12
RU2012145855A (ru) 2014-05-10
US9453025B2 (en) 2016-09-27
US20130178459A1 (en) 2013-07-11
EP2552206A1 (en) 2013-02-06
CA2792941A1 (en) 2011-10-06
US8962648B2 (en) 2015-02-24
TW201136939A (en) 2011-11-01
EP2552206A4 (en) 2013-08-14

Similar Documents

Publication Publication Date Title
IL222080B (en) 6-alkyl-thieno[2,3-c]quinolin-4(5h)-one derivatives
AP2939A (en) Thieno [2,3-B] pyridine derivatives as viral replication inhibitors
IL213993A (en) History of 4,3,2,1-tetrahydropyrido [3,2-b] pyrazine-2-one and pharmaceutical preparations containing them
IL216452A0 (en) 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
ZA201206630B (en) Hetaryl-[1,8]naphthyridine derivatives
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
PT2740476T (pt) Derivados cis-tetra-hidro-espiro (ciclo-hexano-1,1'- pirido [3,4-b] indole) -4-amina
IL220432A (en) History of theo [b – 3,2] pyridinedione and pharmaceutical preparations containing them
IL224903A (en) Imidzo [c – 5,4] quinolines as DNA inhibitors
PT2600719E (pt) 8 ¿ alquilo -2 - substituído 7 ¿ oxo ¿ 7,8 ¿ diidropirido [2,3 ¿ d] pirimidina ¿ 6 ¿ carbonitrilos e seus usos
ZA201108885B (en) 3-([1,2,3]triazole-4yl)-pyrrolo[2,3-b]pyridine derivates
IL218490A0 (en) Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
PL2513119T3 (pl) Pochodne 3,4,4a,10b-tetrahydro-1H-tiopirano-[4,3-c]izochinoliny
IL232717B (en) 3-cyanoaryl-h1-pyrrolo[b-3,2]pyridine derivatives
IL229993A (en) 8 - Alkoxy [1,2,4] triazolo [5,1 – c] pyrimidine– 2
ZA201301313B (en) Herbicidal isoxazolo[5,4-b]pyridines
IL221479A0 (en) Triazolo [4,5-b] pyridin derivatives
PT2646011T (pt) Métodos para a redução da compulsão alimentar periódica ou alimentação compulsiva
ZA201302112B (en) 1,4-oxazepane derivatives
GB2476643B (en) 1,4-Dihydro-1,4-dioxonaphtalene derivatives as anticoagulants
AP2012006419A0 (en) Aminoquinoline derivatives
PL2850070T3 (pl) Pochodne benzo[1,3]dioksyny i ich zastosowanie jako antagonistów LPAR5
PL390846A1 (pl) Pochodne 5,11-dimetylo-5H-indolo[2,3-b]chinoliny
IL219623A0 (en) [1,5]-diazocin derivatives
PL391537A1 (pl) Barwne sulfoniany 9-(2-karboksyfenylo)-3,6-dihydroksy-9H-ksanten-9-yliowe oraz sposób ich otrzymywania

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed